NewsBite

Exclusive

Eucalyptus changes tune and begins selling Ozempic

Nick Bonyhady
Nick BonyhadyTechnology writer

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Key Points

  • Heavily-backed start-up now selling Ozempic, the buzzy weight loss drug.
  • Company argues its other medication, Saxenda, is in short supply.
  • Government drug regulator says Ozempic is scarce, not Saxenda.

Australia’s biggest weight loss drug selling start-up, Eucalyptus, has begun selling Ozempic after previously insisting it only sold medications specifically approved to help people shed kilograms.

Ozempic has been linked to weight loss by a host of celebrities and influencers but is only recommended in Australia as a treatment for type 2 diabetes.

Loading...
Nick Bonyhady is a technology writer for the Australian Financial Review, based in Sydney. He is a former technology editor, industrial relations and politics reporter at the Sydney Morning Herald and Age. Connect with Nick on Twitter. Email Nick at nick.bonyhady@afr.com

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More

Latest In Technology

Fetching latest articles

Most Viewed In Technology

    Original URL: https://www.afr.com/technology/eucalyptus-changes-tune-and-begins-selling-ozempic-20230703-p5dlbs